LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer

This study will utilize tissue and peripheral blood samples for proteomics analysis and establish a longitudinal proteomics cohort at multiple critical treatment time points to explore the research value of proteomics in the diagnosis and treatment of lung cancer. The study includes key time points such as screening, postoperative efficacy prediction, and efficacy prediction after medication.

NCT Number	NCT06778512
Lead Sponsor	The First Affiliated Hospital of Guangzhou Medical University
Conditions	Lung, Lung Cancer, Cancer, NSCLC
Enrollment	2,500 participants
Start Date	2019-06-01
Primary Completion	2026-12-01 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2025-01-16